These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 15823491)

  • 21. Reciprocal association between visceral obesity and adiponectin: in healthy premenopausal women.
    Kwon K; Jung SH; Choi C; Park SH
    Int J Cardiol; 2005 Jun; 101(3):385-90. PubMed ID: 15907405
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adiponectin--a key adipokine in the metabolic syndrome.
    Whitehead JP; Richards AA; Hickman IJ; Macdonald GA; Prins JB
    Diabetes Obes Metab; 2006 May; 8(3):264-80. PubMed ID: 16634986
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Obstructive sleep apnoea syndrome, plasma adiponectin levels, and insulin resistance.
    Makino S; Handa H; Suzukawa K; Fujiwara M; Nakamura M; Muraoka S; Takasago I; Tanaka Y; Hashimoto K; Sugimoto T
    Clin Endocrinol (Oxf); 2006 Jan; 64(1):12-9. PubMed ID: 16402923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adiponectin and hypertension.
    Ohashi K; Ouchi N; Matsuzawa Y
    Am J Hypertens; 2011 Mar; 24(3):263-9. PubMed ID: 20930707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of adiponectin as a potential therapeutic strategy.
    Lim S; Quon MJ; Koh KK
    Atherosclerosis; 2014 Apr; 233(2):721-728. PubMed ID: 24603219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adiponectin represents an independent risk factor for hypertension in middle aged Korean women.
    Lee HS; Lee M; Joung H
    Asia Pac J Clin Nutr; 2007; 16(1):10-5. PubMed ID: 17215175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum adiponectin concentrations predict the developments of type 2 diabetes and the metabolic syndrome in elderly Koreans.
    Choi KM; Lee J; Lee KW; Seo JA; Oh JH; Kim SG; Kim NH; Choi DS; Baik SH
    Clin Endocrinol (Oxf); 2004 Jul; 61(1):75-80. PubMed ID: 15212647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of obesity-associated insulin resistance on mRNA expression of peroxisome proliferator-activated receptor-gamma target genes, in dogs.
    Gayet C; Leray V; Saito M; Siliart B; Nguyen P
    Br J Nutr; 2007 Sep; 98(3):497-503. PubMed ID: 17475082
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liver function parameters, cholesterol, and phospholipid α-linoleic acid are associated with adipokine levels in overweight and obese adults.
    Gray B; Steyn F; Davies PS; Vitetta L
    Nutr Res; 2014 May; 34(5):375-82. PubMed ID: 24916550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes.
    Mojiminiyi OA; Abdella NA; Al Arouj M; Ben Nakhi A
    Int J Obes (Lond); 2007 Feb; 31(2):213-20. PubMed ID: 16755284
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Body adiposity index and other indexes of body composition in the SAPHIR study: association with cardiovascular risk factors.
    Melmer A; Lamina C; Tschoner A; Ress C; Kaser S; Laimer M; Sandhofer A; Paulweber B; Ebenbichler CF
    Obesity (Silver Spring); 2013 Apr; 21(4):775-81. PubMed ID: 23712981
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Statins and diabetes.
    Carmena R; Betteridge DJ
    Semin Vasc Med; 2004 Nov; 4(4):321-32. PubMed ID: 15861314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High plasma C-reactive protein (CRP) is related to low paraoxonase-I (PON-I) activity independently of high leptin and low adiponectin in type 2 diabetes mellitus.
    Dullaart RP; de Vries R; Sluiter WJ; Voorbij HA
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):221-6. PubMed ID: 18505467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adiponectin and cardiovascular disease: mechanisms and new therapeutic approaches.
    Siasos G; Tousoulis D; Kollia C; Oikonomou E; Siasou Z; Stefanadis C; Papavassiliou AG
    Curr Med Chem; 2012; 19(8):1193-209. PubMed ID: 22257055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biological background and role of adiponectin as marker for insulin resistance and cardiovascular risk.
    Schöndorf T; Maiworm A; Emmison N; Forst T; Pfützner A
    Clin Lab; 2005; 51(9-10):489-94. PubMed ID: 16285470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cilostazol ameliorates metabolic abnormalities with suppression of proinflammatory markers in a db/db mouse model of type 2 diabetes via activation of peroxisome proliferator-activated receptor gamma transcription.
    Park SY; Shin HK; Lee JH; Kim CD; Lee WS; Rhim BY; Hong KW
    J Pharmacol Exp Ther; 2009 May; 329(2):571-9. PubMed ID: 19221061
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Telmisartan treatment decreases visceral fat accumulation and improves serum levels of adiponectin and vascular inflammation markers in Japanese hypertensive patients.
    Chujo D; Yagi K; Asano A; Muramoto H; Sakai S; Ohnishi A; Shintaku-Kubota M; Mabuchi H; Yamagishi M; Kobayashi J
    Hypertens Res; 2007 Dec; 30(12):1205-10. PubMed ID: 18344626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aerobic plus resistance training was more effective in improving the visceral adiposity, metabolic profile and inflammatory markers than aerobic training in obese adolescents.
    Dâmaso AR; da Silveira Campos RM; Caranti DA; de Piano A; Fisberg M; Foschini D; de Lima Sanches P; Tock L; Lederman HM; Tufik S; de Mello MT
    J Sports Sci; 2014; 32(15):1435-45. PubMed ID: 24730354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma adiponectin distribution in a Mediterranean population and its association with cardiovascular risk factors and metabolic syndrome.
    Salas-Salvadó J; Granada M; Bulló M; Corominas A; Casas P; Foz M
    Metabolism; 2007 Nov; 56(11):1486-92. PubMed ID: 17950098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.